Antigen-specific production of interleukin (IL)-13 and IL-5 cooperate to mediate IL-4Rα-independent airway hyperreactivity

European Journal of Immunology

Volumn 33, Issue 12, 2003, Pages 3377-3385

  Webb, Dianne C ^a   Mahalingam, Surendran ^a,c   Cai, Yeping ^a   Matthaei, Klaus I ^a   Donaldson, Debra D ^b   Foster, Paul S ^a  

^a Biology and Environment   (Australia)

^b PFIZER INC   (United States)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Allergy; Cytokine receptors; Cytokines; Eosinophils

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; EOSINOPHILIA; FEMALE; HELPER CELL; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BRONCHIAL HYPERREACTIVITY; EOSINOPHILIA; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; MUCUS; OVALBUMIN; PROTEIN SUBUNITS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; RECEPTORS, INTERLEUKIN-4; TH1 CELLS; TH2 CELLS;

EID: 0346121481     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324178     Document Type: Article

References (40)

1. Walker, C., Kaegi, M. K., Braun, P. and Blaser, K., Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin. Immunol. 1991. 88: 935-942.
2. Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R. and Kay, A. B., Predominant TH2-like bronchoalveolar lavage T-lymphocyte population in atopic asthma. N. Engl. J. Med. 1992. 326: 298-304.
3. Corrigan, C. J. and Kay, A. B., T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 1992. 13: 501-507.
4. Kotsimbos, T. C., Ernst, P. and Hamid, Q. A., Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. Proc. Assoc. Am. Phys. 1996. 108: 368-373.
5. Huang, S.-K., Xiao, H.-Q., Kleine-Tebbe, J., Paciotti, G., Marsh, D. G., Lichtenstein, L. M. and Liu, M. C., IL-13 expression at the sites of allergen challenge in patients with asthma. J. Immunol. 1995. 155: 2688-2694.
6. Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locklsley, R. M. and Corry, D. B., Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998. 282: 2261-2263.
7. Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L. and Donaldson, D. D., Interleukin-13: central mediator of allergic asthma. Science 1998. 282: 2258-2261.
8. Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y. and Elias, J. A., Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 1999. 103: 779-788.
9. Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., Senior, R. M. and Elias, J. A., Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1. J. Exp. Med. 2001. 194: 809-821.
10. Hilton, D. J., Zhang, J.-G., Metcalf, D., Alexander, W. S., Nicola, N. A. and Willson, T. A., Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin-4 receptor. Proc. Natl. Acad. Sci. USA 1996. 93: 497-501.
11. Aman, M. J., Tayebi, N., O'biri, N. I., Puri, R. K., Modi, W. S. and Leonard, W. J., cDNA cloning and characterization of the human interleukin 13 receptor a chain. J. Biol. Chem. 1996. 271: 29265-29270.
12. Gauchat, J.-F., Schlagenhauf, E., Feng, N.-P., Moser, R., Yamage, M., Jeannin, P., Alouani, S., Elson, G., Notarangelo, L. D., Wells, T., Eugster, H.-P. and Bonnefoy, J.-Y., A novel 4-kb interleukin-13 receptor a mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/ interleukin-13 receptor. Eur. J. Immunol. 1997. 27: 971-978.
13. Miloux, B., Laurent, P., Bonnin, O., Lupker, J., Caput, D., Vita, N. and Ferrara, P., Cloning of the human IL-13Rα1 chain and reconstitution with the IL-4Rα of a functional IL-4/IL-13 receptor complex. FEBS Lett. 1997. 401: 163-166.
14. Kawakami, K., Taguchi, J., Murata, T. and Puri, R. K., The interleukin-13 receptor α2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. Blood 2001. 97: 2673-2679.
15. Zhang, J.-G., Hilton, D. J., Willson, T. A., McFarlane, C., Roberts, B. A., Moritz, R. L., Simpson, R. J., Alexander, W. S., Metcalf, D. and Nicola, N. A., Identification, purification and characterization of a soluble interleukin (IL)-13-binding protein. J. Biol. Chem. 1997. 272: 9474-9480.
16. Donaldson, D. D., Whitters, M. J., Fitz, L. J., Neben, T. Y., Finnerty, H., Henderson, S. L., O'Hara, R. M. J., Beier, D. R., Turner, K. J., Wood, C. R. and Collins, M., The murine IL-13 receptor α2: molecular cloning, characterization, and comparison with the murine IL-13 receptor α1. J. Immunol. 1998. 161: 2317-2324.
17. Wood, N., Whitters, M. J., Jacobsen, B. A., Witek, J., Syoek, J. P., Kasain, M., Epihimer, M. J., Unger, M., Tanaka, T., Goldman, S. J., Collins, M., Donaldson, D. D. and Grusby, M. J., Enhanced Interleukin(IL)-13 responses in mice lacking IL-13 receptor α2. J. Exp. Med. 2003. 6: 703-709.
18. Ford, J. G., Rennick, D., Donaldson, D. D., Venkayya, R., McArthur, C., Hansell, E., Kurup, V. P., Warnock, M. and Grünig, G., IL-13 and IFNγ: Interactions in lung inflammation. J. Immunol. 2001. 167: 1769-1777.
19. Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J. and Paul, W. E., The IL-4 receptor: Signaling mechanisms and biologic functions. Annu. Rev. Immunol. 1999. 17: 701-738.
20. Mohrs, M., Lacy, D. A. and Locksley, R. M., Stat signals release activated naive Th cells from an anergic checkpoint. J. Immunol. 2003. 170: 1870-1876.
21. Jankovic, D., Kullberg, M., Noben-Trauth, N., Caspar, P., Ward, J. M., Cheever, A. W., Paul, W. E. and Sher, A., Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J. Immunol. 1999. 163: 337-342.
22. Mohrs, M., Holscher, C. and Brombacher, F., Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection. Infect. Immun. 2000. 68: 1773-1780.
23. Noben-Trauth, N., Paul, W. E. and Sacks, D. L., IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmaina major parasite substrains. J. Immunol. 1999. 162: 6132-6140.
24. Yang, M., Hogan, S. P., Henry, P. J., Matthaei, K. I., McKenzie, A. N. J., Young, I. G., Rothenberg, M. E. and Foster, P. S., Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin. Am. J. Respir. Cell Mol. Biol. 2001. 25: 522-530.
25. Mattes, J., Yang, M., Siqueira, A., Clark, K., MacKenzie, J., McKenzie, A. N., Webb, D. C., Matthaei, K. I. and Foster, P. S., IL-13 induces airways hyperreactivity independently of the IL-4Rα chain in the allergic lung. J. Immunol. 2001. 167: 1683-1692.
26. Graber, P., Gretener, D., Herren, S., Aubry, J.-P., Elson, G., Poudrier, J., Lecoanst-Henchoz, S., Alouani, S., Losberger, C., Bonnefoy, J.-Y., Kosco-Vilbois, M. H. and Gauchat, J.-F., The distribution of IL-13 receptor α1 expression on B cells, T cells and monocytes and its regulation by IL-13 and IL-4. Eur. J. Immunol. 1998. 28: 4286-4298.
27. Muchamel, T., Menon, S., Pisacane, P., Howard, M. C. and Cockayne, D. A., IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia. J. Immunol. 1997. 158: 2898-2903.
28. Poudder, J., Graber, R, Herren, S., Gretener, D., Elson, G., Berney, C., Gauchat, J.-F. and Kosco-Vilbois, M. H., A soluble form of IL-13 receptor α1 promotes IgG2a and IgG2b production by murine germinal center B cells. J. Immunol. 1999. 163: 1153-1161.
29. Walter, D. M., McIntire, J. J., Berry, G., McKenzie, A. N., Donaldson, D. D., DeKruyff, R. H. and Umetsu, D. T., Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 2001. 167: 4668-4675.
30. Mattes, J., Yang, M., Mahalingam, S., Kuehr, J., Webb, D. C., Simson, L., Hogan, S. P., Koskinen, A., Dent, L., Rothenberg, M. E., Matthaei, K. I., Young, I. G. and Foster, P. S., Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hypereactivity in experimental asthma. J. Exp. Med. 2002. 195: 1433-1444
31. Hogan, S. P., Matthaei, K. I., Young, J. M., Koskinen, A., Young, I. G. and Foster, P. S., A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J. Immunol. 1998. 161: 1501-1509.
32. + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996. 4: 15-24.
33. + Th2 lymphocyte function. J. Immunol. 2001. 167: 3146-3155.
34. + T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc. Natl. Acad. Sci. USA 1997. 94: 10838-10843.
35. Foster, P. S., Hogan, S. P., Ramsay, A. J., Matthaei, K. I. and Young, I. G., Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 1996. 183: 195-201.
36. Webb, D. C., McKenzie, A. N. J., Koskinen, A. M. L., Yang, M., Mattes, J. and Foster, P. S., Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J. Immunol. 2000. 165: 108-113.
37. Hamelmann, E., Schwarze, J., Takeda, K., Oshiba, A., Larsen, G. L., Irvin, C. G. and Gelfand, E. W., Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 1997. 156: 766-775.
38. + T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperrreactivity, and lung damage in mice. Am. J. Respir. Care Med. 1998. 157: 210-218.
39. Mahalingam, S., Farber, J. M. and Karupiah, G., The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo. J. Virol. 1999. 73: 1479-1491.
40. Schnare, M., Blum, H., Jüttner, S., Röllingholf, M. and Gessner, A., Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4. J. Immunol. 1998. 161: 3484-3492.